Psychotropic Medication Adherence among Community-Based Individuals with Developmental Disabilities and Mental Illness

REFERENCES

• Ahn, J., McCombs, J. S., Jung, C., Croudace, T. J., McDonnell, D., Ascher-Svanum, H., … Shi, L. (2008). Classifying patients by antipsychotic adherence patterns using latent class analysis: Characteristics of nonadherent groups in the California Medicaid (Medi-Cal) program. Value in Health, 11(1), 48–56. doi:10.1111/j.1524-4733.2007.00214.x
   PubMed Web of Science ®Google Scholar
• Allen, K. D., & Warzak, W. J. (2000). The problem of parental nonadherence in clinical behavior analysis: Effective treatment is not enough. Journal of Applied Behavior Analysis, 33(3), 373–91. doi:10.1901/jaba.2000.33-373
   PubMed Web of Science ®Google Scholar
• Ascher-Svanum, H., Faries, D. E., Zhu, B., Ernst, F. R., Swartz, M. S., & Swanson, J. W. (2006). Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care. The Journal of Clinical Psychiatry, 67(3), 453–60.
   PubMed Web of Science ®Google Scholar
• Balkrishnan, R., Naughton, M., Smith, B. P., Manuel, J., & Koman, L. A. (2002). Parent caregiver-related predictors of health care service utilization by children with cerebral palsy enrolled in Medicaid. Journal of Pediatric Health Care, 16(2), 73–78. doi:10.1067/mph.2002.116064
   PubMedGoogle Scholar
• Benner, J. S., Glynn, R. J., Mogun, H., Neumann, P. J., Weinstein, M. C., & Avorn, J. (2014). Long-term persistence in use of statin therapy in elderly patients. The Journal of the American Medical Association, 288(4), 455–61.
   Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. (2013). Facts about developmental disabilities. Retrieved from http://www.cdc.gov/ncbddd/developmentaldisabilities/facts.html
   Google Scholar
• Danielson, E. (2014, July). White paper: Health research data for the real world: The MarketScan® databases. Retrieved July 7, 2014, from Truven Health Analytics.
   Google Scholar
• Deyo, R. A., Cherkin, D. C., & Ciol, M. A. (1992). Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. Journal of Clinical Epidemiology, 45(6), 613–9.
   PubMed Web of Science ®Google Scholar
• Einfeld, S. L., Piccinin, A. M., Mackinnon, A., Hofer, S. M., Taffe, J., Gray, K. M., … Tonge, B. J. (2006). Psychopathology in young people with intellectual disability. JAMA: The Journal of the American Medical Association, 296(16), 1981–9. doi:10.1001/jama.296.16.1981
   PubMed Web of Science ®Google Scholar
• Esbensen, A. J., Greenberg, J. S., Seltzer, M. M., & Aman, M. G. (2009). A longitudinal investigation of psychotropic and non-psychotropic medication use among adolescents and adults with autism spectrum disorders. Journal of Autism and Developmental Disorders, 39(9), 1339–49. doi:10.1007/s10803-009-0750-3
   PubMed Web of Science ®Google Scholar
• Gilmer, T. P., Dolder, C. R., Lacro, J. P., Folsom, D. P., Lindamer, L., Garcia, P., & Jeste, D. V. (2004). Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia. The American Journal of Psychiatry, 161(4), 692–9.
   PubMed Web of Science ®Google Scholar
• Gold, M., Nelson, L., Lake, T., Hurley, R., & Berenson, R. (1995). Behind the curve: A critical assessment of how little is known about arrangements between managed care plans and physicians. Medical Care Research and Review, 52(3), 307–341. doi:10.1177/107755879505200301
   PubMed Web of Science ®Google Scholar
• Harrington, C., & Kang, T. (2008). Disparities in service utilization and expenditures for individuals with developmental disabilities. Disability and Health Journal, 1(4), 184–95. doi:10.1016/j.dhjo.2008.05.004
   PubMed Web of Science ®Google Scholar
• Holden, B., & Gitlesen, J. P. (2004). Psychotropic medication in adults with mental retardation: Prevalence, and prescription practices. Research in Developmental Disabilities, 25(6), 509–21. doi:10.1016/j.ridd.2004.03.004
   PubMed Web of Science ®Google Scholar
• Holden, P., & Neff, J. A. (2000). Intensive outpatient treatment of persons with mental retardation and psychiatric disorder: A preliminary study. Mental Retardation, 38(1), 27–32.
   PubMedGoogle Scholar
• Huneke, N. T. M., Gupta, R., Halder, N., & Chaudhry, N. (2012). Difficult decisions: Are intellectually disabled patients given enough information to consent to medical treatment? Journal of Intellectual Disabilities, 16(4), 265–74. doi:10.1177/1744629512462179
   PubMedGoogle Scholar
• Hurley, A. D., Folstein, M., & Lam, N. (2003). Patients with and without intellectual disability seeking outpatient psychiatric services: Diagnoses and prescribing pattern. Journal of Intellectual Disability Research, 47(Pt 1), 39–50.
   Web of Science ®Google Scholar
• Janowsky, D. S., Barnhill, L. J., Khalid, A. S., & Davis, J. M. (2006). Relapse of aggressive and disruptive behavior in mentally retarded adults following antipsychotic drug withdrawal predicts psychotropic drug use a decade later. The Journal of Clinical Psychiatry, 67(8), 1272–7.
   PubMed Web of Science ®Google Scholar
• Kalb, L. G., Stuart, E. A., Freedman, B., Zablotsky, B., & Vasa, R. (2012). Psychiatric-related emergency department visits among children with an autism spectrum disorder. Pediatric Emergency Care, 28(12), 1269–76. doi:10.1097/PEC.0b013e3182767d96
   PubMed Web of Science ®Google Scholar
• Karve, S., Cleves, M. A., Helm, M., Hudson, T. J., West, D. S., & Martin, B. C. (2009). Prospective validation of eight different adherence measures for use with administrative claims data among patients with schizophrenia. Value in Health: The Journal of the International Society for Pharmacoeconomics and Outcomes Research, 12(6), 989–95. doi:10.1111/j.1524-4733.2009.00543.x
   PubMed Web of Science ®Google Scholar
• Kerker, B. D., Owens, P. L., Zigler, E., & Horwitz, S. M. (2004). Mental health disorders among individuals with mental retardation: Challenges to accurate prevalence estimates. Public Health Reports (Washington, DC: 1974), 119(4), 409–17. doi:10.1016/j.phr.2004.05.005
   PubMed Web of Science ®Google Scholar
• Koller, H., Richardson, S. A., Katz, M., & McLaren, J. (1982). Behavior disturbance in childhood and the early adult years in populations who were and were not mentally retarded. Journal of Preventive Psychiatry, 1(4), 453–468.
   Google Scholar
• Lang, K., Korn, J., Muser, E., Choi, J. C., Abouzaid, S., & Menzin, J. (2011). Predictors of medication nonadherence and hospitalization in Medicaid patients with bipolar I disorder given long-acting or oral antipsychotics. Journal of Medical Economics, 14, 217–26.
   PubMedGoogle Scholar
• Lang, K., Meyers, J., Korn, J. R., Lee, S., Sikirica, M., Crivera, C., … Menzin, J. (2010). Medication adherence and hospitalization among patients with schizophrenia treated with antipsychotics. Psychiatric Services, 61(12), 1239–47.
   PubMed Web of Science ®Google Scholar
• Lewis, M. A., Lewis, C. E., Leake, B., King, B. H., & Lindemann, R. (2002). The quality of health care for adults with developmental disabilities. Public Health Reports (Washington, DC: 1974), 117(2), 174–84.
   PubMed Web of Science ®Google Scholar
• Lott, I. T., McGregor, M., Engelman, L., Touchette, P., Tournay, A., Sandman, C., … Walsh, D. (2004). Longitudinal prescribing patterns for psychoactive medications in community-based individuals with developmental disabilities: Utilization of pharmacy records. Journal of Intellectual Disability Research, 48(Pt 6), 563–71. doi:10.1111/j.1365-2788.2004.00625.x
   Web of Science ®Google Scholar
• Lunsky, Y., Bradley, E., Durbin, J., Koegl, C., Canrinus, M., & Goering, P. (2006). The clinical profile and service needs of hospitalized adults with mental retardation and a psychiatric diagnosis. Psychiatric Services, 57(1), 77–83. doi:10.1176/appi.ps.57.1.77
   PubMed Web of Science ®Google Scholar
• Moore, T. R., & Symons, F. J. (2009). Adherence to behavioral and medical treatment recommendations by parents of children with autism spectrum disorders. Journal of Autism and Developmental Disorders, 39(8), 1173–84. doi:10.1007/s10803-009-0729-0
   PubMed Web of Science ®Google Scholar
• Morstad, D. (2012). How prevalent are intellectual and developmental disabilities in the United States? Retrieved from http://bethesdainstitute.org/document.doc?id=413.
   Google Scholar
• Nau, D. P. (n.d.). Proportion of days covered (PDC) as a preferred method of measuring medication adherence. Retrieved from http://ep.yimg.com/ty/cdn/epill/pdcmpr.pdf.
   Google Scholar
• Parish, S. L., & Lutwick, Z. E. (2005). A critical analysis of the emerging crisis in long-term care for people with developmental disabilities. Social Work, 50(4), 345–54.
   PubMed Web of Science ®Google Scholar
• Pawaskar, M., Burch, S., Seiber, E., Nahata, M., Iaconi, A., & Balkrishnan, R. (2010). Medicaid payment mechanisms: Impact on medication adherence and health care service utilization in type 2 diabetes enrollees. Population Health Management, 13(4), 209–217.
   PubMed Web of Science ®Google Scholar
• Rasaratnam, R., Crouch, K., & Regan, A. (2004). Attitude to medication of parents/primary carers of people with intellectual disability. Journal of Intellectual Disability Research, 48(Pt 8), 754–63. doi:10.1111/j.1365-2788.2004.00597.x
   Web of Science ®Google Scholar
• Rascati, K. L., Richards, K. M., Ott, C. A., Goddard, A. W., Stafkey-Mailey, D., Alvir, J., … Mychaskiw, M. (2011). Adherence, persistence of use, and costs associated with second-generation antipsychotics for bipolar disorder. Psychiatric Services, 62(9), 1032–40.
   PubMed Web of Science ®Google Scholar
• Rush, K. S., Bowman, L. G., Eidman, S. L., Toole, L. M., & Mortenson, B. P. (2004). Assessing psychopathology in individuals with developmental disabilities. Behavior Modification, 28(5), 621–37. doi:10.1177/0145445503259830
   PubMed Web of Science ®Google Scholar
• Sajatovic, M., Valenstein, M., Blow, F. C., Ganoczy, D., & Ignacio, R. V. (2006). Treatment adherence with antipsychotic medications in bipolar disorder. Bipolar Disorders, 8(3), 232–41. doi:10.1111/j.1399-5618.2006.00314.x
   PubMed Web of Science ®Google Scholar
• Shireman, T. I., Reichard, A., Nazir, N., Backes, J. M., & Greiner, K. A. (2010). Quality of diabetes care for adults with developmental disabilities. Disability and Health Journal, 3, 179–85. doi:10.1016/j.dhjo.2009.10.004
   PubMed Web of Science ®Google Scholar
• Singh, N. N., Ellis, C. R., Donatelli, L. S., Williams, D. E., Ricketts, R. W., Goza, A. B., … Singh, Y. N. (1996). Professionals’ perceptions of psychotropic medication in residential factiliteis for individuals with mental retardation. Journal of Intellectual Disability Research, 40(Pt 1), 1–7.
   Web of Science ®Google Scholar
• Spreat, S., Conroy, J. W., & Fullerton, A. (2004). Statewide longitudinal survey of psychotropic medication use for persons with mental retardation: 1994 to 2000. American Journal of Mental Retardation, 109(4), 322–31. doi:10.1352/0895-8017(2004)109<322:SLSOPM>2.0.CO;2
   PubMedGoogle Scholar
• Stephenson, J. J., Tuncelli, O., Gu, T., Eisenberg, D., Panish, J., Crivera, C., … Tunceli, O. (2012). Adherence to oral second-generation antipsychotic medications in patients with schizophrenia and bipolar disorder: Physicians’ perceptions of adherence vs. pharmacy claims. International Journal of Clinical Practice, 66(6), 565–73. doi:10.1111/j.1742-1241.2012.02918.x
   PubMed Web of Science ®Google Scholar
• Sutherland, G., Couch, M. A., & Iacono, T. (2002). Health issues for adults with developmental disability. Research in Developmental Disabilities, 23, 422–45.
   PubMed Web of Science ®Google Scholar
• Tonge, B., & Einfeld, S. (2000). The trajectory of psychiatric disorders in young people with intellectual disabilities. The Australian and New Zealand Journal of Psychiatry, 34(1), 80–4.
   PubMed Web of Science ®Google Scholar
• Tyrer, P., Oliver-Africano, P. C., Ahmed, Z., Bouras, N., Cooray, S., Deb, S., … Crawford, M. (2008). Risperidone, haloperidol, and placebo in the treatment of aggressive challenging behaviour in patients with intellectual disability: A randomised controlled trial. Lancet, 371(9606), 57–63. doi:10.1016/S0140-6736(08)60072-0
   PubMed Web of Science ®Google Scholar
• Valenstein, M., Copeland, L. A., Blow, F. C., McCarthy, J. F., Zeber, J. E., Gillon, L., … Stavenger, T. (2002). Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission. Medical Care, 40(8), 630–9. doi:10.1097/01.MLR.0000021003.43524.64
   PubMed Web of Science ®Google Scholar
• Valk, H. M. J. V. S. L., & Walsh, P. N. (2008). Managing health problems in people with intellectual disabilities. British Medical Journal, 337(December), 1408–1412. doi:10.1136/bmj.a2507
   Google Scholar
• Wang, L., Mandell, D. S., Lawer, L., Cidav, Z., & Leslie, D. L. (2013). Healthcare service use and costs for autism spectrum disorder: A comparison between medicaid and private insurance. Journal of Autism and Developmental Disorders, 43(5), 1057–64. doi:10.1007/s10803-012-1649-y
   PubMed Web of Science ®Google Scholar
• Wu, C.-H., Erickson, S. R., Piette, J. D., & Balkrishnan, R. (2012). The association of race, comorbid anxiety, and antidepressant adherence among Medicaid enrollees with major depressive disorder. Research in Social & Administrative Pharmacy, 8(3), 193–205. doi:10.1016/j.sapharm.2011.04.002
   PubMed Web of Science ®Google Scholar
• Yen, C.-F., Lin, J.-D., Loh, C.-H., Shi, L., & Hsu, S.-W. (2009). Determinants of prescription drug use by adolescents with intellectual disabilities in Taiwan. Research in Developmental Disabilities, 30(6), 1354–66. doi:10.1016/j.ridd.2009.06.002
   PubMed Web of Science ®Google Scholar